| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
15,593 |
14,704 |
$1.77M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
11,068 |
9,921 |
$1.25M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,538 |
2,719 |
$1.10M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,516 |
4,005 |
$580K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
6,453 |
1,749 |
$474K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
5,788 |
1,834 |
$436K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
4,025 |
1,336 |
$348K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,452 |
2,320 |
$258K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
916 |
762 |
$246K |
| 80053 |
Comprehensive metabolic panel |
15,631 |
13,930 |
$181K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
976 |
589 |
$179K |
| 70450 |
Computed tomography, head or brain; without contrast material |
612 |
528 |
$151K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,279 |
1,156 |
$129K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
548 |
416 |
$110K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
281 |
233 |
$77K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
21,181 |
18,164 |
$74K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
857 |
830 |
$74K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,589 |
4,170 |
$73K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
815 |
510 |
$69K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
419 |
257 |
$62K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
599 |
549 |
$59K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,412 |
2,198 |
$43K |
| 36415 |
Collection of venous blood by venipuncture |
15,511 |
13,276 |
$42K |
| 80061 |
Lipid panel |
3,090 |
2,902 |
$41K |
| G0378 |
Hospital observation service, per hour |
635 |
314 |
$39K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
484 |
366 |
$38K |
| 97016 |
|
901 |
233 |
$33K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,264 |
426 |
$31K |
| 71046 |
Radiologic examination, chest; 2 views |
1,510 |
1,382 |
$29K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,217 |
2,050 |
$29K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
4,091 |
3,792 |
$27K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,153 |
1,061 |
$24K |
| 73564 |
|
532 |
467 |
$23K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,431 |
1,961 |
$22K |
| 87088 |
|
1,887 |
1,640 |
$21K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
435 |
401 |
$21K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
50 |
41 |
$18K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,095 |
923 |
$18K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
52 |
41 |
$17K |
| 73630 |
|
559 |
507 |
$16K |
| 82607 |
|
849 |
771 |
$15K |
| 73130 |
|
489 |
418 |
$14K |
| 73030 |
|
392 |
348 |
$13K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
389 |
342 |
$13K |
| 97161 |
|
267 |
250 |
$12K |
| 86803 |
|
469 |
433 |
$12K |
| 73610 |
|
427 |
381 |
$11K |
| 59025 |
Fetal non-stress test |
127 |
64 |
$10K |
| 97162 |
|
253 |
223 |
$10K |
| 84439 |
|
502 |
459 |
$10K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,603 |
3,155 |
$9K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,243 |
1,098 |
$9K |
| 84484 |
|
3,479 |
2,485 |
$9K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
360 |
331 |
$7K |
| 84466 |
|
609 |
556 |
$6K |
| 83735 |
|
3,105 |
2,450 |
$6K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
452 |
151 |
$6K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
389 |
342 |
$6K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
436 |
402 |
$6K |
| 62323 |
|
12 |
12 |
$5K |
| 73110 |
|
175 |
158 |
$5K |
| 83540 |
|
619 |
564 |
$5K |
| 82728 |
|
304 |
281 |
$5K |
| 81001 |
|
6,819 |
6,163 |
$5K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
527 |
426 |
$5K |
| 86780 |
|
177 |
161 |
$4K |
| 86140 |
|
1,035 |
821 |
$4K |
| 81514 |
|
55 |
53 |
$4K |
| 82746 |
|
415 |
381 |
$4K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
242 |
205 |
$4K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
246 |
238 |
$4K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
54 |
44 |
$4K |
| 87186 |
|
559 |
470 |
$4K |
| 71045 |
Radiologic examination, chest; single view |
1,506 |
1,287 |
$3K |
| 84153 |
|
231 |
211 |
$3K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
17 |
17 |
$3K |
| 81003 |
|
1,638 |
1,414 |
$3K |
| 82570 |
|
321 |
288 |
$3K |
| 85610 |
|
1,745 |
1,479 |
$3K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
12 |
12 |
$3K |
| 85652 |
|
606 |
524 |
$2K |
| J3490 |
Unclassified drugs |
1,556 |
765 |
$2K |
| 72100 |
|
60 |
57 |
$2K |
| 86850 |
|
125 |
103 |
$2K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,797 |
3,250 |
$2K |
| 84703 |
|
2,309 |
1,909 |
$2K |
| 85027 |
|
251 |
207 |
$2K |
| 73502 |
|
63 |
57 |
$2K |
| 82565 |
|
489 |
350 |
$2K |
| 83690 |
|
2,606 |
2,137 |
$2K |
| 83880 |
|
824 |
694 |
$2K |
| 83605 |
|
1,399 |
1,084 |
$2K |
| 71250 |
|
17 |
13 |
$2K |
| 87340 |
|
66 |
64 |
$1K |
| 82043 |
|
216 |
205 |
$1K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
64 |
51 |
$1K |
| 85730 |
|
1,717 |
1,438 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,048 |
1,622 |
$1K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,805 |
2,051 |
$1K |
| 82248 |
|
676 |
543 |
$1K |
| 84702 |
|
65 |
42 |
$1K |
| 80051 |
|
273 |
184 |
$1K |
| 82150 |
|
621 |
502 |
$1K |
| 82947 |
|
317 |
222 |
$1K |
| 86900 |
|
128 |
104 |
$1K |
| 73562 |
|
46 |
41 |
$1K |
| 92523 |
|
12 |
12 |
$996.54 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,696 |
1,201 |
$960.35 |
| 84520 |
|
470 |
347 |
$835.83 |
| 86038 |
|
28 |
25 |
$821.21 |
| 96376 |
|
521 |
294 |
$762.52 |
| 73080 |
|
31 |
29 |
$680.10 |
| 86901 |
|
128 |
104 |
$674.05 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,355 |
297 |
$614.06 |
| 84550 |
|
106 |
94 |
$610.53 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
15 |
13 |
$559.67 |
| 74018 |
|
13 |
12 |
$559.18 |
| 87077 |
|
497 |
288 |
$498.39 |
| 85018 |
|
24 |
24 |
$420.16 |
| 77003 |
|
570 |
485 |
$401.34 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
19 |
14 |
$378.48 |
| 85379 |
|
513 |
443 |
$336.98 |
| 90715 |
|
13 |
12 |
$283.10 |
| 82550 |
|
61 |
49 |
$227.08 |
| 87070 |
|
57 |
43 |
$216.70 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
704 |
420 |
$160.26 |
| 84481 |
|
17 |
13 |
$146.09 |
| 80076 |
|
13 |
13 |
$120.59 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,448 |
1,977 |
$118.30 |
| 87634 |
|
329 |
266 |
$116.10 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
594 |
397 |
$108.78 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
347 |
246 |
$100.17 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,253 |
1,005 |
$57.16 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
628 |
506 |
$52.78 |
| 87205 |
|
37 |
25 |
$45.38 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
419 |
311 |
$28.92 |
| J1815 |
Injection, insulin, per 5 units |
19 |
12 |
$25.16 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,870 |
1,369 |
$24.12 |
| 84156 |
|
12 |
12 |
$20.14 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
541 |
421 |
$16.00 |
| J2704 |
Injection, propofol, 10 mg |
984 |
819 |
$15.87 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
361 |
223 |
$6.58 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
172 |
113 |
$5.87 |
| J3360 |
Injection, diazepam, up to 5 mg |
14 |
14 |
$5.45 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
215 |
168 |
$5.12 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
291 |
224 |
$5.05 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
63 |
59 |
$5.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
345 |
262 |
$3.64 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
120 |
110 |
$3.53 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
209 |
144 |
$3.30 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
168 |
39 |
$2.18 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
99 |
77 |
$2.07 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
191 |
156 |
$0.92 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
33 |
26 |
$0.58 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
223 |
188 |
$0.53 |
| J1940 |
Injection, furosemide, up to 20 mg |
27 |
13 |
$0.05 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,003 |
1,596 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
180 |
156 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
38 |
38 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
18 |
14 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
45 |
35 |
$0.00 |
| A9270 |
Non-covered item or service |
762 |
102 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
95 |
72 |
$0.00 |
| 00813 |
|
12 |
12 |
$0.00 |
| 82803 |
|
70 |
55 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
13 |
12 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
18 |
12 |
$0.00 |